These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 16431341

  • 1. Targeted therapy for systemic sclerosis.
    Steen V.
    Autoimmun Rev; 2006 Feb; 5(2):122-4. PubMed ID: 16431341
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Systemic sclerosis/scleroderma: a treatable multisystem disease.
    Hinchcliff M, Varga J.
    Am Fam Physician; 2008 Oct 15; 78(8):961-8. PubMed ID: 18953973
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Scleroderma--clinical and pathological advances.
    Denton CP, Black CM.
    Best Pract Res Clin Rheumatol; 2004 Jun 15; 18(3):271-90. PubMed ID: 15158741
    [Abstract] [Full Text] [Related]

  • 7. Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody.
    Steen VD, Lucas M, Fertig N, Medsger TA.
    J Rheumatol; 2007 Nov 15; 34(11):2230-5. PubMed ID: 17937469
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Systemic sclerosis: an update.
    Varga J.
    Bull NYU Hosp Jt Dis; 2008 Nov 15; 66(3):198-202. PubMed ID: 18937632
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
    Hoyles RK, Ellis RW, Wellsbury J, Lees B, Newlands P, Goh NS, Roberts C, Desai S, Herrick AL, McHugh NJ, Foley NM, Pearson SB, Emery P, Veale DJ, Denton CP, Wells AU, Black CM, du Bois RM.
    Arthritis Rheum; 2006 Dec 15; 54(12):3962-70. PubMed ID: 17133610
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Renal complications and scleroderma renal crisis.
    Denton CP, Lapadula G, Mouthon L, Müller-Ladner U.
    Rheumatology (Oxford); 2009 Jun 15; 48 Suppl 3():iii32-5. PubMed ID: 19487221
    [Abstract] [Full Text] [Related]

  • 17. Vasoactive therapies in systemic sclerosis.
    Riemekasten G, Sunderkötter C.
    Rheumatology (Oxford); 2006 Oct 15; 45 Suppl 3():iii49-51. PubMed ID: 16987836
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.